"High serum selenium associated with elevated LDL and total cholesterol
By Helen Albert
21 January 2010
Atherosclerosis 2009; Advance online publication
MedWire News: High levels of serum selenium are associated with elevated total and low-density lipoprotein (LDL) cholesterol, report US researchers.
The results add weight to those of a previous UK study, reported by MedWire News, that reported an association between high plasma selenium and an adverse lipid profile.
Eliseo Guallar (Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland) and colleagues carried out a cross-sectional analysis of 1159 individuals aged 56.8 years on average who participated in the National Health and Nutrition Examination Survey (NHANES) 2003-2004."
MedWire News: Calcitriol, the active form of vitamin D, has been found to induce the tumor-suppressing protein CCAAT enhancer-binding protein (C/EBP)α, which can inhibit the growth of breast cancer cells, researchers report.
MedWire News: Eating two eggs a day, as part of an energy-restricted weight-loss diet, does not increase levels of 'bad' or total cholesterol, results of a UK study show.
"MedWire News: High levels of selenium in the blood may worsen prostate cancer in some men who already have the disease, results of a US study suggest.
In recent years, selenium supplements have been promoted as a means of preventing prostate cancer, largely based on observational studies that found higher prostate cancer incidence and mortality in geographical areas that are naturally low in selenium, compared with in those that are naturally high in the mineral.
However, the current research findings suggest that "if you already have prostate cancer, it may be a bad thing to take selenium," said study researcher Dr Philip Kantoff, from the Dana-Farber Cancer Institute in Boston, Massachusetts, USA."
"Lancet 2010; Advance online publication
MedWire News: There is a U-shaped relationship between glycated hemoglobin (HbA1c) levels and mortality in people with diabetes, say researchers, meaning that intensive glucose-lowering therapy could be as harmful as uncontrolled hyperglycemia.
Writing in The Lancet, Craig Currie (Cardiff University, UK) and team say that if their findings are confirmed then diabetes guidelines may need to be revised to include a lower as well as an upper HbA1c threshold.
Currie's team used the UK General Practice Research Database from November 1986 to November 2008 to obtain data on two cohorts of patients aged 50 years and older with Type 2 diabetes.
The patients comprised 27,965 individuals whose treatment had been intensified from oral monotherapy to combination therapy with oral blood-glucose lowering agents, and 20,005 who had changed to insulin-containing regimens."
"MedWire News: Zinc supplements could increase the risk for coronary heart disease (CHD) in healthy people by decreasing high-density lipoprotein (HDL) cholesterol levels, researchers claim.
Initial findings from a meta-analysis in 14,238 participants from 20 trials suggested no impact of zinc supplements on plasma lipoprotein levels. But a secondary analysis in healthy individuals showed that zinc was associated with a significant decrease in plasma HDL concentrations.
Furthermore, zinc was linked with a significant decrease in HDL cholesterol levels among participants with Type 2 diabetes or those undergoing hemodialysis.
The researchers suggest the result in patients with diabetes may relate to the action of zinc in determining insulin levels.
The meta-analysis included 33 interventions investigating the impact of zinc on lipid levels. The mean dose of elemental zinc used was 58 mg per day, which the researchers note is beyond the recommended upper level of intake of 40 mg."